RetinAI develops products to make research and health institutions more efficient using latest technologies in machine learning and computer vision. We build software tools to collect, organise and analyse health data from the eyes, empowering communities of healthcare professionals and patients with unique data analysis. We integrate our solutions inside the target server infrastructure and into medical devices, interconnecting the whole clinical pipeline and reducing the time and cost it takes to do clinical and research work, enabling our users to optimise their efforts and to provide a better care. Our vision is to support the transition from reactive to preventive and patient-specific medicine for high-impact diseases in ophthalmology and neurology.

To learn about the innovation in MedTech industry, Cédric travelled to Bern and conducted a must-see interview with Carlos Ciller, CEO & co-founder of RetinAI. In this episode, we are discovering how AI can be applied to healthcare and what are the current trends in ophthalmology. Carlos Ciller is a PhD holder in Machine Learning & Medical Imaging in Ophthalmology. He studied at EPFL in Lausanne and also spent a year at Imperial College in London. As he explains, he was always looking for a way to put technology and innovation at the service of humanity.